CVE-2024-10476: becton dickinson & co bd bactec™ blood culture system Use of Default Credentials
Vulnerability summary
CVE-2024-10476 is a high (CVSS 8.0) Use of Default Credentials vulnerability in becton dickinson & co bd bactec™ blood culture system. EPSS estimates a 0.24% chance of exploitation in the next 30 days, higher than 13.7% of scored vulnerabilities.
Timeline
- 17-12-2024PublishedVulnerability first disclosed.
- 17-12-2024Last modifiedVulnerability information updated.
Description
Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.
CVSS metrics
2 scores · 2 sources · 1 version- NVDNIST8.0HighCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
EPSS trend
Probability
0.24%
Chance of exploitation in the next 30 days
Percentile
14%
Versus all other CVEs
30-day change
0.00 pp
From 0.24% on 22-09-2026
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Becton dickinson & co6 products
- bd bactec™ blood culture system≤ 7.20
- bd cor™ system≤ 8.90
- bd epicenter™ microbiology data management system≤ 7.45
- bd max™ system≤ 6.10
- bd phoenix™ m50 automated microbiology system≤ 2.70
1 vendor · 6 products